Clinical trial

A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus

NCT00836940

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2008-06-01

PhasePHASE2

Study timeline

Study start (unknown)2008-06-01Date precision: month

Registry last updated2009-09-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

GRC 8200DRUG

Sponsors & collaborators

Glenmark Pharmaceuticals Europe Ltd. (R&D)lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00836940 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.